Elite Laboratories acquires abbreviated drug applications from Mikah Pharma - MarketLine Financial Deals

Elite Laboratories acquires abbreviated drug applications from Mikah Pharma

Elite Laboratories acquires abbreviated drug applications from Mikah Pharma - MarketLine Financial Deals
Elite Laboratories acquires abbreviated drug applications from Mikah Pharma
Published Aug 01, 2013
2 pages — Published Aug 01, 2013
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Elite Laboratories, Inc. (ELI) has acquired 13 abbreviated new drug applications from Mikah Pharma, LLC, a pharmaceutical company, for a consideration of $10 million, payable pursuant to a secured convertible note due in August 2016.

  
Source:
Document ID
MA142141_130927
Country
Ticker
ELI=US
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Elite Laboratories acquires abbreviated drug applications from Mikah Pharma" Aug 01, 2013. Alacra Store. Dec 07, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Elite-Laboratories-acquires-abbreviated-drug-applications-from-Mikah-Pharma-2052-97773>
  
APA:
MarketLine Financial Deals. (2013). Elite Laboratories acquires abbreviated drug applications from Mikah Pharma Aug 01, 2013. New York, NY: Alacra Store. Retrieved Dec 07, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Elite-Laboratories-acquires-abbreviated-drug-applications-from-Mikah-Pharma-2052-97773>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.